The end of an era of cancer drug discovery: life without new drug targets

Immuno-Oncology Insights 2022; 3(4), 189–194


Published: 12 April 2022
Armen Mardiros, Alexander Kamb

 Armen Mardiros & Alexander Kamb A2 Biotherapeutics, Inc. 

“We believe that cell therapy is the therapeutic modality best suited to overcome the present challenges in oncology.”